|
1
|
Abraham C and Cho JH: Inflammatory bowel
disease. N Engl J Med. 361:2066–2078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Podolsky DK: Inflammatory bowel disease. N
Engl J Med. 347:417–429. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peterson LW and Artis D: Intestinal
epithelial cells: Regulators of barrier function and immune
homeostasis. Nat Rev Immunol. 14:141–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jaszewski R, Tolia V, Ehrinpreis MN,
Bodzin JH, Peleman RR, Korlipara R and Weinstock JV: Increased
colonic mucosal angiotensin I and II concentrations in Crohn's
colitis. Gastroenterology. 98:1543–1548. 1990.PubMed/NCBI
|
|
5
|
Garg M, Burrell LM, Velkoska E, Griggs K,
Angus PW, Gibson PR and Lubel JS: Upregulation of circulating
components of the alternative renin-angiotensin system in
inflammatory bowel disease: A pilot study. J Renin Angiotensin
Aldosterone Syst. 16:559–569. 2015. View Article : Google Scholar
|
|
6
|
Bregonzio C, Armando I, Ando H, Jezova M,
Baiardi G and Saavedra JM: Anti-inflammatory effects of angiotensin
II AT1 receptor antagonism prevent stress-induced gastric injury.
Am J Physiol Gastrointest Liver Physiol. 285:G414–G423. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuno A, Yamada T, Masuda K, Ogawa K,
Sogawa M, Nakamura S, Nakazawa T, Ohara H, Nomura T, Joh T, et al:
Angiotensin-converting enzyme inhibitor attenuates pancreatic
inflammation and fibrosis in male Wistar Bonn/Kobori rats.
Gastroenterology. 124:1010–1019. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inokuchi Y, Morohashi T, Kawana I,
Nagashima Y, Kihara M and Umemura S: Amelioration of
2,4,6-trinitrobenzene sulphonic acid induced colitis in
angiotensinogen gene knockout mice. Gut. 54:349–356. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katada K, Yoshida N, Suzuki T, Okuda T,
Mizushima K, Takagi T, Ichikawa H, Naito Y, Cepinskas G and
Yoshikawa T: Dextran sulfate sodium-induced acute colonic
inflammation in angiotensin II type 1a receptor deficient mice.
Inflamm Res. 57:84–91. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leri A, Claudio PP, Li Q, Wang X, Reiss K,
Wang S, Malhotra A, Kajstura J and Anversa P: Stretch-mediated
release of angiotensin II induces myocyte apoptosis by activating
p53 that enhances the local renin-angiotensin system and decreases
the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest.
101:1326–1342. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang W, Sun L, Xiao W and Yang H:
Essential role of angiotensin receptors in the modulation of
intestinal epithelial cell apoptosis. J Pediatr Gastroenterol Nutr.
57:562–569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pawlowski J and Kraft AS: Bax-induced
apoptotic cell death. Proc Natl Acad Sci USA. 97:529–531. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang Y, Swartz-Basile DA, Swietlicki EA,
Yi L, Rubin DC and Levin MS: Bax is required for resection-induced
changes in apoptosis, proliferation, and members of the extrinsic
cell death pathways. Gastroenterology. 126:220–230. 2004.
View Article : Google Scholar
|
|
14
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View
Article : Google Scholar
|
|
15
|
Morris GP, Beck PL, Herridge MS, Depew WT,
Szewczuk MR and Wallace JL: Hapten-induced model of chronic
inflammation and ulceration in the rat colon. Gastroenterology.
96:795–803. 1989.PubMed/NCBI
|
|
16
|
Wengrower D, Zanninelli G, Latella G,
Necozione S, Metanes I, Israeli E, Lysy J, Pines M, Papo O and
Goldin E: Losartan reduces trinitrobenzene sulphonic acid-induced
colorectal fibrosis in rats. Can J Gastroenterol. 26:33–39.
2012.PubMed/NCBI
|
|
17
|
Appleyard CB and Wallace JL: Reactivation
of hapten-induced colitis and its prevention by anti-inflammatory
drugs. Am J Physiol. 269:G119–G125. 1995.PubMed/NCBI
|
|
18
|
Liu W, Chen Y, Golan MA, Annunziata ML, Du
J, Dougherty U, Kong J, Musch M, Huang Y, Pekow J, et al:
Intestinal epithelial vitamin D receptor signaling inhibits
experimental colitis. J Clin Invest. 123:3983–3996. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su L, Nalle SC, Shen L, Turner ES, Singh
G, Breskin LA, Khramtsova EA, Khramtsova G, Tsai PY, Fu YX, et al:
TNFR2 activates MLCK-dependent tight junction dysregulation to
cause apoptosis-mediated barrier loss and experimental colitis.
Gastroenterology. 145:407–415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brand S: Crohn's disease: Th1, Th17 or
both? The change of a paradigm: New immunological and genetic
insights implicate Th17 cells in the pathogenesis of Crohn's
disease. Gut. 58:1152–1167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hume GE and Radford-Smith GL: ACE
inhibitors and angiotensin II receptor antagonists in Crohn's
disease management. Expert Rev Gastroenterol Hepatol. 2:645–651.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Spencer AU, Yang H, Haxhija EQ, Wildhaber
BE, Greenson JK and Teitelbaum DH: Reduced severity of a mouse
colitis model with angiotensin converting enzyme inhibition. Dig
Dis Sci. 52:1060–1070. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okawada M, Koga H, Larsen SD, Showalter
HD, Turbiak AJ, Jin X, Lucas PC, Lipka E, Hillfinger J, Kim JS and
Teitelbaum DH: Use of enterally delivered angiotensin II type 1a
receptor antagonists to reduce the severity of colitis. Dig Dis
Sci. 56:2553–2565. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Rayford H and Uhal BD: Essential
roles for angiotensin receptor AT1a in bleomycin-induced apoptosis
and lung fibrosis in mice. Am J Pathol. 163:2523–2530. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hirasawa K, Sato Y, Hosoda Y, Yamamoto T
and Hanai H: Immunohistochemical localization of angiotensin II
receptor and local renin-angiotensin system in human colonic
mucosa. J Histochem Cytochem. 50:275–282. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Petnehazy T, Cooper D, Stokes KY, Russell
J, Wood KC and Granger DN: Angiotensin II type 1 receptors and the
intestinal microvascular dysfunction induced by ischemia and
reperfusion. Am J Physiol Gastrointest Liver Physiol.
290:G1203–G1210. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mori M, Stokes KY, Vowinkel T, Watanabe N,
Elrod JW, Harris NR, Lefer DJ, Hibi T and Granger DN: Colonic blood
flow responses in experimental colitis: Time course and underlying
mechanisms. Am J Physiol Gastrointest Liver Physiol.
289:G1024–G1029. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deniz M, Cetinel S and Kurtel H: Blood
flow alterations in TNBS-induced colitis: Role of endothelin
receptors. Inflamm Res. 53:329–336. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Garrelds IM, Heiligers JP, Van Meeteren
ME, Duncker DJ, Saxena PR, Meijssen MA and Zijlstra FJ: Intestinal
blood flow in murine colitis induced with dextran sulfate sodium.
Dig Dis Sci. 47:2231–2236. 2002. View Article : Google Scholar : PubMed/NCBI
|
